Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Cross-sectional analysis of cognitive function in the MACS with multivariate normative comparisons.

Wang Z, Molsberry SA, Cheng Y, Kingsley L, Levine AJ, Martin E, Munro CA, Ragin A, Rubin LH, Sacktor N, Seaberg EC, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2019 Jul 22. doi: 10.1097/QAD.0000000000002312. [Epub ahead of print]

PMID:
31335803
2.

Neurocognitive Complications of HIV Infection in Low-Income Countries.

Vecchio A, Sacktor N, Saylor D, Robertson K.

Curr Top Behav Neurosci. 2019 Jul 12. doi: 10.1007/7854_2019_92. [Epub ahead of print]

PMID:
31297744
3.

Letter to the Editor.

Abassi M, Sacktor N.

J Neurovirol. 2019 Jul 5. doi: 10.1007/s13365-019-00774-7. [Epub ahead of print] No abstract available.

PMID:
31278534
4.

Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.

Rubin LH, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Kisakye A, Batte J, Mayanja R, Anok A, Lofgren SM, Boulware DR, Dastgheyb R, Reynolds SJ, Quinn TC, Gray RH, Wawer MJ, Sacktor N.

J Neurovirol. 2019 Jun 19. doi: 10.1007/s13365-019-00768-5. [Epub ahead of print]

PMID:
31218522
5.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group.

Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.

6.

Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study.

Rubin LH, Gustafson D, Hawkins KL, Zhang L, Jacobson LP, Becker JT, Munro CA, Lake JE, Martin E, Levine A, Brown TT, Sacktor N, Erlandson KM.

Neurology. 2019 Jul 16;93(3):e261-e271. doi: 10.1212/WNL.0000000000007779. Epub 2019 Jun 14.

PMID:
31201294
7.

Interleukin-6 is associated with mortality and neuropsychiatric outcomes in antiretroviral-naïve adults in Rakai, Uganda.

Saylor D, Kumar A, Nakigozi G, Anok A, Batte J, Kisakye A, Mayanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Pardo CA, Sacktor N.

J Neurovirol. 2019 Jun 4. doi: 10.1007/s13365-019-00759-6. [Epub ahead of print]

PMID:
31165368
8.

Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients.

Dastgheyb RM, Sacktor N, Franklin D, Letendre S, Marcotte T, Heaton R, Grant I, McArthur JC, Rubin LH, Haughey NJ.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):61-70. doi: 10.1097/QAI.0000000000002093.

PMID:
31107302
9.

Neuropsychological changes in efavirenz switch regimens.

Li Y, Wang Z, Cheng Y, Becker JT, Martin E, Levine A, Rubin LH, Sacktor N, Ragin A, Ho K.

AIDS. 2019 Jul 1;33(8):1307-1314. doi: 10.1097/QAD.0000000000002206.

PMID:
30932965
10.

Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.

Rubin LH, Springer G, Martin EM, Seaberg EC, Sacktor NC, Levine A, Valcour VG, Young MA, Becker JT, Maki PM.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):274-283. doi: 10.1097/QAI.0000000000002029.

PMID:
30893126
11.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

PMID:
30890191
12.

Effects of comorbidity burden and age on brain integrity in HIV.

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D Jr, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Fennema-Notestine C; CHARTER Study Group.

AIDS. 2019 Jun 1;33(7):1175-1185. doi: 10.1097/QAD.0000000000002192.

PMID:
30870195
13.

Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.

Sacktor N, Saylor D, Nakigozi G, Nakasujja N, Robertson K, Grabowski MK, Kisakye A, Batte J, Mayanja R, Anok A, Gray RH, Wawer MJ.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):216-223. doi: 10.1097/QAI.0000000000001992.

PMID:
30865184
14.

Changes in cognition precede changes in HRQoL among HIV+ males: Longitudinal analysis of the multicenter AIDS cohort study.

Jones JD, Kuhn T, Levine A, Sacktor N, Munro CA, Teplin LA, D'Souza G, Martin EM, Becker JT, Miller EN, Hinkin CH.

Neuropsychology. 2019 Mar;33(3):370-378. doi: 10.1037/neu0000530.

PMID:
30816783
15.

Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients.

Khuder SS, Chen S, Letendre S, Marcotte T, Grant I, Franklin D, Rubin LH, Margolick JB, Jacobson LP, Sacktor N, D'Souza G, Stosor V, Lake JE, Rapocciolo G, McArthur JC, Dickens AM, Haughey NJ.

Neurology. 2019 Mar 19;92(12):e1344-e1353. doi: 10.1212/WNL.0000000000007125. Epub 2019 Feb 20.

PMID:
30787163
16.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.

Pérez-Valero I, Ellis R, Heaton R, Deutsch R, Franklin D, Clifford DB, Collier A, Gelman B, Marra C, McCutchan JA, Navis A, Sacktor N, Simpson D, Grant I, Letendre S.

AIDS. 2019 Mar 1;33(3):475-481. doi: 10.1097/QAD.0000000000002074.

PMID:
30702516
17.

Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men.

Okafor CN, Plankey MW, Li M, Chen X, Surkan PJ, Shoptaw S, Martin E, Cohen R, Sacktor N, Cook RL.

Subst Use Misuse. 2019;54(4):525-537. doi: 10.1080/10826084.2018.1495736. Epub 2019 Jan 30.

PMID:
30700235
18.

Vitamin D is not associated with HIV-associated neurocognitive disorder in Rakai, Uganda.

Saylor D, Nakigozi G, Pardo CA, Kisakye A, Kumar A, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Sacktor N.

J Neurovirol. 2019 Jun;25(3):410-414. doi: 10.1007/s13365-018-00719-6. Epub 2019 Jan 22.

PMID:
30671778
19.

Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.

Phillips NJ, Thomas KGF, Myer L, Sacktor N, Zar HJ, Stein DJ, Hoare J.

AIDS. 2019 Apr 1;33(5):815-824. doi: 10.1097/QAD.0000000000002144.

PMID:
30649059
20.

Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Popov M, Molsberry SA, Lecci F, Junker B, Kingsley LA, Levine A, Martin E, Miller E, Munro CA, Ragin A, Seaberg E, Sacktor N, Becker JT.

Brain Imaging Behav. 2019 Jan 9. doi: 10.1007/s11682-018-0026-7. [Epub ahead of print]

PMID:
30623289
21.

Headache prevalence and its functional impact among HIV-infected adults in rural Rakai District, Uganda.

Sohail S, Nakigozi G, Anok A, Batte J, Kisakye A, Mayanja R, Nakasujja N, Robertson KR, Gray RH, Wawer MJ, Sacktor N, Saylor D.

J Neurovirol. 2019 Apr;25(2):248-253. doi: 10.1007/s13365-018-0710-9. Epub 2019 Jan 3.

PMID:
30607892
22.

Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.

Kisakye A, Saylor D, Sacktor N, Nakigozi G, Nakasujja N, Robertson K, Anok A, Wawer M, Gray R.

AIDS Care. 2019 Jul;31(7):836-839. doi: 10.1080/09540121.2018.1557591. Epub 2018 Dec 15.

PMID:
30554522
23.

White matter damage, neuroinflammation, and neuronal integrity in HAND.

Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2019 Feb;25(1):32-41. doi: 10.1007/s13365-018-0682-9. Epub 2018 Oct 5.

24.

HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings.

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A; AIDS Clinical Trials Group.

Clin Infect Dis. 2018 Sep 13. doi: 10.1093/cid/ciy767. [Epub ahead of print]

PMID:
30219843
25.

HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.

Robertson K, Oladeji B, Jiang H, Kumwenda J, Supparatpinyo K, Campbell T, Hakim J, Tripathy S, Hosseinipour M, Marra CM; 5199 study team, Kumarasamy N, Evans S, Vecchio A, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, Firnhaber C, Price R, Marcus C, Berzins B, Masih R, Lalloo U, Sanne I, Yosief S, Walawander A, Nair A, Sacktor N, Hall C; AIDS Clinical Trials Group.

Clin Infect Dis. 2018 Aug 20. doi: 10.1093/cid/ciy718. [Epub ahead of print]

26.

Intraindividual variability in neurocognitive performance: No influence due to HIV status or self-reported effort.

Levine AJ, Martin E, Munro CA, Sacktor N, Horvath S, Becker JT; Multicenter AIDS Cohort Study–Neuropsychology Working Group.

J Clin Exp Neuropsychol. 2018 Dec;40(10):1044-1049. doi: 10.1080/13803395.2018.1508554. Epub 2018 Aug 20.

PMID:
30124355
27.

Differences in Cognitive Function Between Women and Men With HIV.

Maki PM, Rubin LH, Springer G, Seaberg EC, Sacktor N, Miller EN, Valcour V, Young MA, Becker JT, Martin EM; Neuropsychology Working Groups of the Womenʼs Interagency HIV Study and the Multicenter AIDS Cohort Study.

J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):101-107. doi: 10.1097/QAI.0000000000001764.

PMID:
29847476
28.

HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.

Wu M, Fatukasi O, Yang S, Alger J, Barker PB, Hetherington H, Kim T, Levine A, Martin E, Munro CA, Parrish T, Ragin A, Sacktor N, Seaberg E, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2018 Aug 24;32(13):1803-1810. doi: 10.1097/QAD.0000000000001891.

PMID:
29794829
29.

Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.

Molsberry SA, Cheng Y, Kingsley L, Jacobson L, Levine AJ, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N, Becker JT; Neuropsychology Working Group of the Multicenter AIDS Cohort Study.

AIDS. 2018 Jul 31;32(12):1679-1688. doi: 10.1097/QAD.0000000000001865.

30.

Impact of glycemic status on longitudinal cognitive performance in men with and without HIV infection.

Yang J, Jacobson LP, Becker JT, Levine A, Martin EM, Munro CA, Palella FJ, Lake JE, Sacktor NC, Brown TT.

AIDS. 2018 Aug 24;32(13):1849-1860. doi: 10.1097/QAD.0000000000001842. Erratum in: AIDS. 2019 Mar 15;33(4):767.

PMID:
29746300
31.

Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy.

Rubin LH, Sacktor N, Creighton J, Du Y, Endres CJ, Pomper MG, Coughlin JM.

AIDS. 2018 Jul 31;32(12):1661-1667. doi: 10.1097/QAD.0000000000001858.

32.

7T Brain MRS in HIV Infection: Correlation with Cognitive Impairment and Performance on Neuropsychological Tests.

Mohamed M, Barker PB, Skolasky RL, Sacktor N.

AJNR Am J Neuroradiol. 2018 Apr;39(4):704-712. doi: 10.3174/ajnr.A5547. Epub 2018 Feb 15.

33.

Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men.

Armstrong NM, Surkan PJ, Treisman GJ, Sacktor NC, Irwin MR, Teplin LA, Stall RC, Jacobson LP, Abraham AG.

Aging Ment Health. 2019 Apr;23(4):507-514. doi: 10.1080/13607863.2017.1423037. Epub 2018 Feb 9.

PMID:
29424569
34.

Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial.

Sacktor N, Skolasky RL, Moxley R, Wang S, Mielke MM, Munro C, Steiner J, Nath A, Haughey N, McArthur J.

J Neurovirol. 2018 Feb;24(1):16-27. doi: 10.1007/s13365-017-0587-z. Epub 2017 Oct 23.

35.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

36.

Changing clinical phenotypes of HIV-associated neurocognitive disorders.

Sacktor N.

J Neurovirol. 2018 Apr;24(2):141-145. doi: 10.1007/s13365-017-0556-6. Epub 2017 Jul 27.

37.

Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.

Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC; Multicenter AIDS Cohort Study.

Lancet HIV. 2017 Sep;4(9):e411-e422. doi: 10.1016/S2352-3018(17)30098-X. Epub 2017 Jul 14.

38.

Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda.

Saylor D, Nakigozi G, Nakasujja N, Robertson K, Gray RH, Wawer MJ, Sacktor N.

Neurology. 2017 Aug 1;89(5):485-491. doi: 10.1212/WNL.0000000000004136. Epub 2017 Jul 5.

39.

Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.

Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte T, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, Tharakan R, McArthur JC, Fox H, Haughey NJ.

AIDS. 2017 Jun 19;31(10):1365-1378. doi: 10.1097/QAD.0000000000001503.

40.

Impairments of Motor Function While Multitasking in HIV.

Kronemer SI, Mandel JA, Sacktor NC, Marvel CL.

Front Hum Neurosci. 2017 Apr 28;11:212. doi: 10.3389/fnhum.2017.00212. eCollection 2017.

41.

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.

Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss CS, Heaton RK, Ellis RJ, Schork N, Marra CM, Collier AC, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, McCutchan JA, Barnholtz-Sloan JS, Franklin DR, Rosario D, Letendre SL, Grant I, Kallianpur AR; CHARTER Study Group.

Am J Med Genet B Neuropsychiatr Genet. 2017 Jun;174(4):413-426. doi: 10.1002/ajmg.b.32530. Epub 2017 Apr 26.

42.

Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus.

Armstrong NM, Surkan PJ, Treisman GJ, Sacktor NC, Irwin MR, Teplin LA, Stall R, Martin EM, Becker JT, Munro C, Levine AJ, Jacobson LP, Abraham AG.

J Neurovirol. 2017 Aug;23(4):558-567. doi: 10.1007/s13365-017-0527-y. Epub 2017 Apr 20.

43.

The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment.

Sacktor N, Soldan A, Grega M, Farrington L, Cai Q, Wang MC, Gottesman RF, Turner RS, Albert M; BIOCARD Research Team.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):114-119. doi: 10.1097/WAD.0000000000000194.

44.

Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.

Levine AJ, Martin E, Sacktor N, Munro C, Becker J; Multicenter AIDS Cohort Study-Neuropsychology Working Group.

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):203-210. doi: 10.1097/QAI.0000000000001371.

45.

The association between physical activity and cognition in men with and without HIV infection.

Monroe AK, Zhang L, Jacobson LP, Plankey MW, Brown TT, Miller EN, Martin E, Becker JT, Levine AJ, Ragin A, Sacktor NC.

HIV Med. 2017 Sep;18(8):555-563. doi: 10.1111/hiv.12490. Epub 2017 Mar 13.

46.

Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.

Lloyd TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, Pak K, Sacktor N, Mammen AL.

Neurology. 2017 Apr 11;88(15):1454-1460. doi: 10.1212/WNL.0000000000003821. Epub 2017 Mar 10.

47.

Transcriptome analyses identify key cellular factors associated with HIV-1-associated neuropathogenesis in infected men.

Venkatachari NJ, Jain S, Walker L, Bivalkar-Mehla S, Chattopadhyay A, Bar-Joseph Z, Rinaldo C, Ragin A, Seaberg E, Levine A, Becker J, Martin E, Sacktor N, Ayyavoo V.

AIDS. 2017 Mar 13;31(5):623-633. doi: 10.1097/QAD.0000000000001379.

48.

Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.

Abassi M, Morawski BM, Nakigozi G, Nakasujja N, Kong X, Meya DB, Robertson K, Gray R, Wawer MJ, Sacktor N, Boulware DR.

J Neurovirol. 2017 Jun;23(3):369-375. doi: 10.1007/s13365-016-0505-9. Epub 2016 Dec 19.

49.

Visceral fat is associated with brain structure independent of human immunodeficiency virus infection status.

Lake JE, Popov M, Post WS, Palella FJ, Sacktor N, Miller EN, Brown TT, Becker JT.

J Neurovirol. 2017 Jun;23(3):385-393. doi: 10.1007/s13365-016-0507-7. Epub 2016 Dec 15.

50.

Association of midlife smoking status with change in processing speed and mental flexibility among HIV-seropositive and HIV-seronegative older men: the Multicenter AIDS Cohort Study.

Akhtar-Khaleel WZ, Cook RL, Shoptaw S, Miller EN, Sacktor N, Surkan PJ, Becker J, Teplin LA, Beyth RJ, Price C, Plankey M.

J Neurovirol. 2017 Apr;23(2):239-249. doi: 10.1007/s13365-016-0496-6. Epub 2016 Nov 26.

Supplemental Content

Loading ...
Support Center